$0.370
-0.0286 (-7.18%)
At Close: Jun 03, 2026
WILKES-BARRE, Pa. and SUNNYVALE, Calif.
New Strong Sell Stocks for April 30th
10:31am, Friday, 30'th Apr 2021
ARAY, EBS, FARM, SHLX, and TPB have been added to the Zacks Rank #5 (Strong Sell) List on April 30, 2021
SUNNYVALE, Calif., April 29, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that Accuray customers took the top two positions in the MArkerless Lung Target Tracking CHalleng
Accuray's (ARAY) CEO Josh Levine on Q3 2021 Results - Earnings Call Transcript
09:40pm, Tuesday, 27'th Apr 2021
Accuray's (ARAY) CEO Josh Levine on Q3 2021 Results - Earnings Call Transcript
Accuray Reports Third Quarter Fiscal 2021 Financial Results
04:07pm, Tuesday, 27'th Apr 2021
SUNNYVALE, Calif., April 27, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported its financial results for the third quarter of fiscal 2021 ended March 31, 2021.
Accuray Receives Shonin Approval for ClearRT™ Helical kVCT Imaging, CE Mark Expected by End of June; Expands Commercial Launch
07:30am, Thursday, 22'nd Apr 2021
SUNNYVALE, Calif., April 22, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the innovative ClearRT™ helical fan-beam kVCT imaging* capability has now been in clinic
Accuray to Report Third Quarter Fiscal 2021 Financial Results on April 27, 2021
04:05pm, Tuesday, 13'th Apr 2021
SUNNYVALE, Calif., April 13, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the third quarter of fiscal year 2021, ended March 31, 2021, after the marke
Accuray Appoints Healthcare Executive and Physician Byron C. Scott to Board of Directors
04:30pm, Friday, 19'th Feb 2021
SUNNYVALE, Calif., Feb. 19, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today the appointment of Byron C. Scott, M.D., MBA to the company's Board of Directors, effective as of F
Accuray to Participate in BTIG's Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference
07:30am, Friday, 05'th Feb 2021
SUNNYVALE, Calif., Feb. 5, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today announced its participation in BTIG's Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Confe
Accuray Is Seeing Green Shoots For Its Large China Opportunity
01:52pm, Thursday, 28'th Jan 2021
Accuray announced better than expected fiscal Q2 results, with the first revenue from its China Type A license backlog. Orders remain erratic, but the backlog was up 11% yoy and stable sequentially, a
Accuray Incorporated (ARAY) CEO Josh Levine on Q2 2021 Results - Earnings Call Transcript
09:29pm, Wednesday, 27'th Jan 2021
Accuray Incorporated (ARAY) CEO Josh Levine on Q2 2021 Results - Earnings Call Transcript
Accuray (ARAY) Beats Q2 Earnings and Revenue Estimates
07:05pm, Wednesday, 27'th Jan 2021
Accuray (ARAY) delivered earnings and revenue surprises of 600.00% and 4.96%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
10 Stocks Under $10 to Buy Before They Soar
09:05am, Wednesday, 27'th Jan 2021
One of the counterintuitive dynamics of the pandemic-disrupted year in 2020 was the rise of Wall Street. But that doesn't mean you've missed the boat, as these stocks under $10 demonstrate.
Accuray (ARAY) Releases Encouraging Breast Cancer Study Results
12:02pm, Tuesday, 26'th Jan 2021
Accuray (ARAY) releases positive data from a prospective trial of 338 women with low-risk breast cancer.
Seven-year Data Shows Accuray TomoTherapy® System Provides Excellent Long-Term Control of Low-Risk Breast Cancer
07:30am, Tuesday, 19'th Jan 2021
SUNNYVALE, Calif., Jan. 19, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that data from a prospective, phase II trial of 338 women with low-risk breast cancer showed 98.8 p
Sign In
Buy ARAY